Wogonin Influences Osteosarcoma Stem Cell Stemness Through ROS-dependent Signaling

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Osteosarcoma is a highly malignant bone cancer with frequent relapse and metastasis.
• Wogonin, a flavonoid from Scutellaria baicalensis, exhibits known anticancer properties.
• Osteosarcoma stem cells contribute to tumor progression and recurrence.

Purpose of the Study:

• To investigate the anticancer effects of wogonin on osteosarcoma stem cells.
• To elucidate the mechanisms underlying wogonin's action on these cells.

Main Methods:

• In vitro assessment of wogonin's cytotoxic effects on CD133+ Cal72 osteosarcoma stem cells.
• Utilized MTT assay, transwell assay, sphere-formation assay, flow cytometry, immunocytochemistry, and western blotting.
• Investigated the role of reactive oxygen species (ROS) in wogonin's mechanism of action.

Main Results:

• Wogonin significantly suppressed stem cell characteristics and related gene expression in osteosarcoma cells.
• These effects were mediated by the regulation of reactive oxygen species (ROS) levels.
• The observed effects of wogonin were reversible with N-acetylcysteine, a ROS scavenger.

Conclusions:

• Wogonin demonstrates potent anticancer activity against osteosarcoma stem cells.
• Regulation of ROS-related pathways and stem cell genes is a key mechanism of wogonin's efficacy.
• Wogonin shows promise as a therapeutic agent for osteosarcoma clinical management.